128 related articles for article (PubMed ID: 8263537)
21. Post-translational processing of the neurotensin/neuromedin N precursor in the central nervous system of the rat--II. Immunohistochemical localization of maturation products.
Woulfe J; Lafortune L; de Nadai F; Kitabgi P; Beaudet A
Neuroscience; 1994 May; 60(1):167-81. PubMed ID: 8052410
[TBL] [Abstract][Full Text] [Related]
22. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
23. Characterization of neurotensin binding sites on rat mesencephalic cells in primary culture.
Dana C; Pelaprat D; Vial M; Brouard A; Lhiaubet AM; Rostene W
Brain Res Dev Brain Res; 1991 Aug; 61(2):259-64. PubMed ID: 1661213
[TBL] [Abstract][Full Text] [Related]
24. Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes.
Li XM; Finnman UB; von Euler G; Hedlund PB; Fuxe K
Neurosci Lett; 1993 Jun; 155(2):121-4. PubMed ID: 8104321
[TBL] [Abstract][Full Text] [Related]
25. Neurotensin and neuromedin N undergo distinct catabolic processes in murine astrocytes and primary cultured neurons.
Vincent B; Vincent JP; Checler F
Eur J Biochem; 1994 Apr; 221(1):297-306. PubMed ID: 7909519
[TBL] [Abstract][Full Text] [Related]
26. [Preparation of iodinated standards for quantitative radioautography in vitro using a tritium-sensitive film].
Rostène W; Mourre C
C R Acad Sci III; 1985; 301(5):245-50. PubMed ID: 2998569
[TBL] [Abstract][Full Text] [Related]
27. Anatomical substrate for neurotensin-acetylcholine interactions in the rat basal forebrain.
Szigethy E; Wenk GL; Beaudet A
Peptides; 1988; 9(6):1227-34. PubMed ID: 2854624
[TBL] [Abstract][Full Text] [Related]
28. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.
Checler F; Vincent JP; Kitabgi P
Eur J Pharmacol; 1986 Jul; 126(3):239-44. PubMed ID: 3019713
[TBL] [Abstract][Full Text] [Related]
29. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas.
Reubi JC; Waser B; Schaer JC; Laissue JA
Int J Cancer; 1999 Jul; 82(2):213-8. PubMed ID: 10389755
[TBL] [Abstract][Full Text] [Related]
30. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
Azriel Y; Burcher E
J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
[TBL] [Abstract][Full Text] [Related]
31. Evidence for specific N-terminal galanin fragment binding sites in the rat brain.
Hedlund PB; Yanaihara N; Fuxe K
Eur J Pharmacol; 1992 Dec; 224(2-3):203-5. PubMed ID: 1281778
[TBL] [Abstract][Full Text] [Related]
32. Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors.
Augeron C; Voisin T; Maoret JJ; Berthon B; Laburthe M; Laboisse CL
Am J Physiol; 1992 Mar; 262(3 Pt 1):G470-6. PubMed ID: 1312794
[TBL] [Abstract][Full Text] [Related]
33. Specific binding of tritiated neurotensin to rat brain membranes: characterization and regional distribution.
Goedert M; Pittaway K; Williams BJ; Emson PC
Brain Res; 1984 Jun; 304(1):71-81. PubMed ID: 6744039
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1 interaction with neuroregulatory systems: selective enhancement by recombinant human and mouse interleukin-1 of in vitro opioid peptide receptor binding in rat brain.
Wiedermann CJ
J Neurosci Res; 1989 Feb; 22(2):172-80. PubMed ID: 2468786
[TBL] [Abstract][Full Text] [Related]
35. Human umbilical vein endothelial cells express high affinity neurotensin receptors coupled to intracellular calcium release.
Schaeffer P; Laplace MC; Savi P; Pflieger AM; Gully D; Herbert JM
J Biol Chem; 1995 Feb; 270(7):3409-13. PubMed ID: 7852427
[TBL] [Abstract][Full Text] [Related]
36. Distribution of 125I-neurotensin binding sites in human forebrain: comparison with the localization of acetylcholinesterase.
Szigethy E; Quirion R; Beaudet A
J Comp Neurol; 1990 Jul; 297(4):487-98. PubMed ID: 2166757
[TBL] [Abstract][Full Text] [Related]
37. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
38. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
Walker MW; Miller RJ
Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
[TBL] [Abstract][Full Text] [Related]
39. Neurotensin and neuromedin N brain levels after fornix transection: evidence for an efficient neurotensin precursor processing in subicular neurons.
Nicot A; Bidard JN; Kitabgi P; Lhiaubet AM; Masuo Y; Palkovits M; Rostène W; Bérod A
Brain Res; 1995 Dec; 702(1-2):279-83. PubMed ID: 8846090
[TBL] [Abstract][Full Text] [Related]
40. Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain.
Zsürger N; Chabry J; Coquerel A; Vincent JP
Brain Res; 1992 Jul; 586(2):303-10. PubMed ID: 1325861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]